Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers

Por Ysebaert, L, Laprévotte, E, Klein, C, Quillet-Mary, A
Publicado no Blood Cancer J (2015)

Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients

Por Boissard, F, Fournié, J-J, Quillet-Mary, A, Ysebaert, L, Poupot, M
Publicado no Blood Cancer J (2015)

Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment

Por Betrian, S, Ysebaert, L, Heider, K H, Delord, J P, Fournié, J J, Quillet-Mary, A
Publicado no Blood Cancer J (2016)

3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution

Por Grgurevic, S, Berquet, L, Quillet-Mary, A, Laurent, G, Récher, C, Ysebaert, L, Cazaux, C, Hoffmann, J S
Publicado no Blood Cancer J (2016)

Nurse-like cells impact on disease progression in chronic lymphocytic leukemia

Por Boissard, F, Laurent, C, Ramsay, A G, Quillet-Mary, A, Fournié, J-J, Poupot, M, Ysebaert, L
Publicado no Blood Cancer J (2016)

Functional assessment of p53 in chronic lymphocytic leukemia

Por Le Garff-Tavernier, M, Blons, H, Nguyen-Khac, F, Pannetier, M, Brissard, M, Gueguen, S, Jacob, F, Ysebaert, L, Susin, S A, Merle-Béral, H
Publicado em 2011

The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells

Por Kheirallah, S, Fruchon, S, Ysebaert, L, Blanc, A, Capilla, F, Marrot, A, AlSaati, T, Frenois, F X, Benhadji, K A, Fournié, J J, Laurent, G, Bezombes, C
Publicado em 2013